Providence Swedish today announced the official opening of the Paul G. Allen Research Center at Providence Swedish Cancer Institute (PSCI). The new center takes a highly collaborative, sophisticated approach to improving the experience and outcome for every cancer patient by advancing modern oncology research to transform clinical care and treatment.
“We are thrilled to officially open the Paul G. Allen Research Center, a focused extension of our long-standing, robust clinical trials program, to enhance resources available to our researchers and collaborators. The model convenes a broad range of problem solvers by inviting competitive proposals from physicians across our institution, stewarding the best research ideas and creating an optimal environment for them to collaborate with academic and industry partners,” said Elizabeth Wako, M.D., Swedish Health Services president and CEO. “The center provides advanced analytics for specimens and data, while bringing together a broad range of clinical, biologic and computer scientists at the forefront of their respective fields. In effect, creating a nimble, responsive environment to drive innovation, united behind a mission to improve care. Our physician researchers are the secret sauce. They know firsthand existing gaps, develop ideas and evaluate promising treatments to identify care improvement opportunities.”
